{ "resourceType" : "CodeSystem", "id" : "TreatmentRegimen", "text" : { "status" : "generated", "div" : "

Generated Narrative: CodeSystem TreatmentRegimen

This case-insensitive code system https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen defines the following codes:

CodeDisplayDefinition
toplusfem 2+5 eller lign, eks. CT2+5 eller lign, eks. CT
aida AIDAAIDA
all_ved ALL vedligeholdALL vedligehold
atoatra ATO+ATRAATO+ATRA
azacitidinmono Azacitidin monoterapiAzacitidin monoterapi
azacitidinvene Azacitidin-venetoclaxAzacitidin-venetoclax
hydrea HydreaHydrea
hdara_c Hd-Ara-c +- supplementHd-Ara-c +- supplement
ade ADE +- supplementADE +- supplement
da DA +- supplementDA +- supplement
da31087 DA inkl. 3+10, 3+8, 3+7DA inkl. 3+10, 3+8, 3+7
da31087my DA inkl. 3+10, 3+8, 3+7 + mylotargDA inkl. 3+10, 3+8, 3+7 + mylotarg
da31087mi DA inkl. 3+10, 3+8, 3+7 + midostaurinDA inkl. 3+10, 3+8, 3+7 + midostaurin
flag FLAG +- supplementFLAG +- supplement
flagmito FLAG-Ida eller lign inkl FLAG, Mito-FLAGFLAG-Ida eller lign inkl FLAG, Mito-FLAG
flagmitovene FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclaxFLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax
gilteritinib GilteritinibGilteritinib
idarac IdAraCIdAraC
inotuzumab Inotuzumab ozogamicinInotuzumab ozogamicin
mace MACE +- supplementMACE +- supplement
midac MidACMidAC
midostaurin_ved Midostaurin vedligeholdMidostaurin vedligehold
ldara LdARA-C +- supplementLdARA-C +- supplement
atra ATRAATRA
apl_mt APL-vedligeholdsbehandlingAPL-vedligeholdsbehandling
azacytidin_supplement 5-Azacytidin +- supplement5-Azacytidin +- supplement
blinatumomab BlinatumomabBlinatumomab
vyxeos Vyxeos +- supplementVyxeos +- supplement
nopho_2008 NOPHO-2008NOPHO-2008
all_mt ALL vedligeholdelsesbehandlingALL vedligeholdelsesbehandling
other_ikke Anden ikke-intensivAnden ikke-intensiv
other_eks Anden eksperimentelAnden eksperimentel
other_semi Anden semiintensiv (f.eks. Plan B)Anden semiintensiv (f.eks. Plan B)
other_int Anden intensiv (f.eks. BISHOP, Plan A)Anden intensiv (f.eks. BISHOP, Plan A)
hyper_cvad Hyper-CVADHyper-CVAD
alltogether_mt ALLtogetherALLtogether
experimental anden behl incl anden experimentelanden behl incl anden experimentel
" }, "url" : "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen", "version" : "2.16.0", "name" : "TreatmentRegimen", "title" : "Treatment regimen", "status" : "active", "date" : "2022-07-12T00:00:00+02:00", "publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact" : [{ "name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom" : [{ "system" : "url", "value" : "https://trifork.com" }, { "system" : "email", "value" : "rbk@trifork.com" }] }], "description" : "Treatment regimen", "caseSensitive" : false, "content" : "complete", "count" : 37, "concept" : [{ "code" : "toplusfem", "display" : "2+5 eller lign, eks. CT", "definition" : "2+5 eller lign, eks. CT" }, { "code" : "aida", "display" : "AIDA", "definition" : "AIDA" }, { "code" : "all_ved", "display" : "ALL vedligehold", "definition" : "ALL vedligehold" }, { "code" : "atoatra", "display" : "ATO+ATRA", "definition" : "ATO+ATRA" }, { "code" : "azacitidinmono", "display" : "Azacitidin monoterapi", "definition" : "Azacitidin monoterapi" }, { "code" : "azacitidinvene", "display" : "Azacitidin-venetoclax", "definition" : "Azacitidin-venetoclax" }, { "code" : "hydrea", "display" : "Hydrea", "definition" : "Hydrea" }, { "code" : "hdara_c", "display" : "Hd-Ara-c +- supplement", "definition" : "Hd-Ara-c +- supplement" }, { "code" : "ade", "display" : "ADE +- supplement", "definition" : "ADE +- supplement" }, { "code" : "da", "display" : "DA +- supplement", "definition" : "DA +- supplement" }, { "code" : "da31087", "display" : "DA inkl. 3+10, 3+8, 3+7", "definition" : "DA inkl. 3+10, 3+8, 3+7" }, { "code" : "da31087my", "display" : "DA inkl. 3+10, 3+8, 3+7 + mylotarg", "definition" : "DA inkl. 3+10, 3+8, 3+7 + mylotarg" }, { "code" : "da31087mi", "display" : "DA inkl. 3+10, 3+8, 3+7 + midostaurin", "definition" : "DA inkl. 3+10, 3+8, 3+7 + midostaurin" }, { "code" : "flag", "display" : "FLAG +- supplement", "definition" : "FLAG +- supplement" }, { "code" : "flagmito", "display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG", "definition" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG" }, { "code" : "flagmitovene", "display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax", "definition" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax" }, { "code" : "gilteritinib", "display" : "Gilteritinib", "definition" : "Gilteritinib" }, { "code" : "idarac", "display" : "IdAraC", "definition" : "IdAraC" }, { "code" : "inotuzumab", "display" : "Inotuzumab ozogamicin", "definition" : "Inotuzumab ozogamicin" }, { "code" : "mace", "display" : "MACE +- supplement", "definition" : "MACE +- supplement" }, { "code" : "midac", "display" : "MidAC", "definition" : "MidAC" }, { "code" : "midostaurin_ved", "display" : "Midostaurin vedligehold", "definition" : "Midostaurin vedligehold" }, { "code" : "ldara", "display" : "LdARA-C +- supplement", "definition" : "LdARA-C +- supplement" }, { "code" : "atra", "display" : "ATRA", "definition" : "ATRA" }, { "code" : "apl_mt", "display" : "APL-vedligeholdsbehandling", "definition" : "APL-vedligeholdsbehandling" }, { "code" : "azacytidin_supplement", "display" : "5-Azacytidin +- supplement", "definition" : "5-Azacytidin +- supplement" }, { "code" : "blinatumomab", "display" : "Blinatumomab", "definition" : "Blinatumomab" }, { "code" : "vyxeos", "display" : "Vyxeos +- supplement", "definition" : "Vyxeos +- supplement" }, { "code" : "nopho_2008", "display" : "NOPHO-2008", "definition" : "NOPHO-2008" }, { "code" : "all_mt", "display" : "ALL vedligeholdelsesbehandling", "definition" : "ALL vedligeholdelsesbehandling" }, { "code" : "other_ikke", "display" : "Anden ikke-intensiv", "definition" : "Anden ikke-intensiv" }, { "code" : "other_eks", "display" : "Anden eksperimentel", "definition" : "Anden eksperimentel" }, { "code" : "other_semi", "display" : "Anden semiintensiv (f.eks. Plan B)", "definition" : "Anden semiintensiv (f.eks. Plan B)" }, { "code" : "other_int", "display" : "Anden intensiv (f.eks. BISHOP, Plan A)", "definition" : "Anden intensiv (f.eks. BISHOP, Plan A)" }, { "code" : "hyper_cvad", "display" : "Hyper-CVAD", "definition" : "Hyper-CVAD" }, { "code" : "alltogether_mt", "display" : "ALLtogether", "definition" : "ALLtogether" }, { "code" : "experimental", "display" : "anden behl incl anden experimentel", "definition" : "anden behl incl anden experimentel" }] }